DrugPatentWatch Database Preview

ZURAMPIC Drug Profile

« Back to Dashboard

When do Zurampic patents expire, and when can generic versions of Zurampic launch?

Zurampic is a drug marketed by Ironwood Pharms Inc and is included in one NDA. There are nine patents protecting this drug.

This drug has one hundred and ninety patent family members in forty countries.

The generic ingredient in ZURAMPIC is lesinurad. Two suppliers are listed for this compound. Additional details are available on the lesinurad profile page.

Summary for ZURAMPIC

International Patents:	190
US Patents:	9
Applicants:	1
NDAs:	1
Suppliers / Packagers:	2
Bulk Api Vendors:	55
Patent Applications:	60
Drug Prices:	Drug price information for ZURAMPIC
Prior Art and Litigation Support	Order Prior Art and Litigation support for ZURAMPIC
DailyMed Link:	ZURAMPIC at DailyMed

Generic Entry Opportunity Date for ZURAMPIC

NDA:

207988

Dosage:

TABLET;ORAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for ZURAMPIC

Drug Class	Urate Transporter 1 Inhibitor
Mechanism of Action	Urate Transporter 1 Inhibitors Cytochrome P450 3A Inducers

Synonyms for ZURAMPIC

(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid

{[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid

09ERP08I3W

2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid

2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid

2-(5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid

2-[[5-Bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic acid

2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid

2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetic acid

2-{[5-broMo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid

3777AH

878672-00-5

AC-29310

Acetic acid, 2-((5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)-

Acetic acid,[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-

ACN-050764

AK323774

AKOS027327368

BCP06435

BDBM37953

C17H14BrN3O2S

CHEBI:90929

CHEMBL2105720

CS-1389

D09921

DB11560

EX-A1289

FGQFOYHRJSUHMR-UHFFFAOYSA-N

GTPL7673

HY-15258

KB-78121

KS-00000LAE

LESINURAD

Lesinurad (RDEA-594)

Lesinurad (RDEA594 pound(c)

Lesinurad (RDEA594)

Lesinurad (USAN/INN)

Lesinurad [USAN:INN]

Lesinurad, >=98% (HPLC)

MolPort-039-138-666

RDEA 594

RDEA-594

RDEA594

s4640

SB16705

SC-94287

SCHEMBL842962

UNII-09ERP08I3W

US10093631, Compound Lesinurad

W-5949

ZINC84757007

Zurampic (TN)

US Patents and Regulatory Information for ZURAMPIC

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ironwood Pharms Inc	ZURAMPIC	lesinurad	TABLET;ORAL	207988-001	Dec 22, 2015		RX	Yes	Yes
Ironwood Pharms Inc	ZURAMPIC	lesinurad	TABLET;ORAL	207988-001	Dec 22, 2015		RX	Yes	Yes
Ironwood Pharms Inc	ZURAMPIC	lesinurad	TABLET;ORAL	207988-001	Dec 22, 2015		RX	Yes	Yes			Y

International Patents for ZURAMPIC

Country	Patent Number	Estimated Expiration
Denmark	2217577
Poland	2658846
World Intellectual Property Organization (WIPO)	2009070740

Supplementary Protection Certificates for ZURAMPIC

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2217577	PA2019003	Lithuania		PRODUCT NAME: ALOPURINOLIS/LESINURADAS ARBA JO FRAMACINIU POZIURIU PRIIMTINA DRUSKA ARBA DRUSKOS; REGISTRATION NO/DATE: EU/1/18/1300 20180823
2217577	300970	Netherlands		PRODUCT NAME: DUZALLO - ALLOPURINOL/LESINURAD OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/18/1300 20180827
2135608	PA2016024,C2135608	Lithuania		PRODUCT NAME: LESINURADAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/15/1080 20160218